Page 42 - Demo

BOEHRINGER INGELHM ASTRAZENECA INOVA MSD ANTINEOPLAST+IMMUNOMODUL $37,654,163 $30,933,755 $26,190,850 $25,615,989 719,563 1,298,848 343,975 598,836 MACITENTAN $905,480 PERINDOPRIL $1,770,231 11% 25% Value Change (%) 64% 26% 31% 46% 25% Value ($) $26,609,312 $24,803,798 $23,991,513 $22,766,983 $18,367,196 10% 30% Volume change (%) 64% 34% 34% 30% 30% Volume (units) 5,945,403 656,383 1,248,287 5,344,641 1,791,486 Pharmacy Value Value Change Top 5 Molecules by Value ADALIMUMAB USTEKINUMAB IBRUTINIB ETANERCEPT ENZALUTAMIDE $506,294,607 18% Pharmacy Volume Volume Change Value of change ($) $5,505,572 $11,000,732 $5,786,376 $2,520,893 $2,249,236 Value of change ($) $11,000,732 $10,456,725 $5,919,003 $5,786,376 $5,505,572 Pharmacy Volume Volume Change Value of change ($) $18,882,003 $11,503,690 $4,705,279 $2,074,877 $1,227,646 Value of change ($) $18,882,003 $11,503,690 $4,705,279 $2,074,877 $1,227,646 Pharmacy Volume Volume Change Value of change ($) $4,843,292 $6,864,613 $2,292,456 5,890,620 0% Ranked by value of change SACUBITRIL + VALSARTAN ROSUVASTATIN ATORVASTATIN CANDESARTAN CILEXETIL PERINDOPRIL Top 5 Corporate % Shares (Wholesale) APOTEX NOVARTIS MSD MYLAN AUSTRALIA ASTRAZENECA G.U.SYSTEM & SEX HORMONES Value of change ($) $6,864,613 $4,843,292 $2,292,456 $2,011,597 $1,770,231 Pharmacy Volume Volume Change Value of change ($) -$11,515,521 $105,997 $2,453,915 $1,486,267 $904,186 Value of change ($) $2,453,915 $1,486,267 $1,260,657 $1,045,200 $992,514 Pharmacy Volume Volume Change Top Molecule Growth QRT vs same QRT LY ADALIMUMAB USTEKINUMAB IBRUTINIB ETANERCEPT ENZALUTAMIDE Ranked by value of change USTEKINUMAB PALBOCICLIB TOFACITINIB IBRUTINIB ADALIMUMAB Top 5 Corporate % Shares (Wholesale) JANSSEN CILAG ABBVIE NOVARTIS PFIZER ASTELLAS PHARMA AU BLOOD + B.FORMING ORGANS Value ($) $80,214,145 $50,791,191 $28,593,776 $27,430,231 $22,818,370 Value Change (%) 7% 28% 25% 10% 11% Value Change (%) 28% 675% 40% 25% 7% Value ($) $115,965,938 $89,340,686 $83,007,270 $60,987,260 $26,751,211 Volume (units) 64,671 11,903 3,136 27,836 6,298 Volume change (%) 15% 28% 24% 10% 11% Volume change (%) 28% 677% 40% 24% 15% Volume (units) 204,252 72,066 97,560 878,493 25,296 Pharmacy Value Value Change Top 5 Molecules by Value $136,955,104 1% 4,059,780 18% Pharmacy Value Value Change Top 5 Molecules by Value APIXABAN RIVAROXABAN IRON FERRIC DABIGATRAN ETEXILATE TICAGRELOR $171,584,202 33% 3,064,585 27% SILDENAFIL TADALAFIL DUTASTERIDE + TAMSULOSIN TAMSULOSIN LEVONORGESTREL Top Molecule Growth QRT vs same QRT LY SILDENAFIL TADALAFIL DUTASTERIDE + TAMSULOSIN TAMSULOSIN LEVONORGESTREL Ranked by value of change DUTASTERIDE + TAMSULOSIN TAMSULOSIN ESTRADIOL MIRABEGRON TESTOSTERONE Top 5 Corporate % Shares (Wholesale) BAYER PHARMA UPJOHN LILLY MSD SANDOZ SYSTEMIC ANTI-INFECTIVES Value ($) $24,109,457 $12,389,083 $9,033,830 $7,575,471 $7,402,844 Value Change (%) -32% 1% 37% 24% 14% Value Change (%) 37% 24% 22% 34% 21% Value ($) $28,064,781 $18,531,714 $12,850,972 $12,330,435 $10,357,488 Volume (units) 479,225 80,072 432,862 144,835 90,869 Volume change (%) 18% 3% 37% 24% 23% Volume change (%) 37% 24% 22% 37% 29% Volume (units) 684,478 174,050 95,780 151,414 406,374 Top Molecule Growth QRT vs same QRT LY APIXABAN RIVAROXABAN IRON FERRIC DABIGATRAN ETEXILATE TICAGRELOR Ranked by value of change APIXABAN RIVAROXABAN IRON FERRIC DABIGATRAN ETEXILATE TICAGRELOR Top 5 Corporate % Shares (Wholesale) BRISTOLMYER SQUIBB BAYER PHARMA VIFOR PHARMA BOEHRINGER INGELHM ASTRAZENECA CARDIOVASCULAR SYSTEM Value ($) $58,361,961 $46,551,677 $18,362,671 $11,130,773 $8,190,657 Value Change (%) 48% 33% 34% 23% 18% Value Change (%) 48% 33% 34% 23% 18% Value ($) $58,361,961 $46,551,677 $18,309,433 $12,760,927 $8,190,657 Volume (units) 714,779 609,473 119,417 144,444 66,526 Volume change (%) 48% 33% 25% 23% 18% Volume change (%) 48% 33% 25% 23% 18% Volume (units) 714,779 609,473 119,033 210,244 66,526 Pharmacy Value Value Change Top 5 Molecules by Value $178,725,975 3% 21,726,472 6% Pharmacy Value Value Change Top 5 Molecules by Value ROSUVASTATIN SACUBITRIL + VALSARTAN ATORVASTATIN MACITENTAN PERINDOPRIL $220,700,672 21% 28,963,955 29% Top Molecule Growth QRT vs same QRT LY SOFOSBUVIR + VELPATASVIR GLECAPREVIR + PIBRENTASVIR BICTEGRAVIR + EMTRICITABINE + TENOFOVIR ALAFENAMIDE EMTRICITABINE + TENOFOVIR DISOPROXIL TENOFOVIR DISOPROXIL Ranked by value of change BICTEGRAVIR + EMTRICITABINE + TENOFOVIR ALAFENAMIDE OSELTAMIVIR SOFOSBUVIR + VELPATASVIR + VOXILAPREVIR AMOXICILLIN + CLAVULANIC ACID AMOXICILLIN Top 5 Corporate % Shares (Wholesale) GILEAD SCIENCES ABBVIE MYLAN AUSTRALIA APOTEX VIIV HEALTHCARE MUSCULO-SKELETAL SYSTEM Pharmacy Value $108,469,537 Value Change 24% Value of change ($) -$12,699,001 -$2,191,980 $8,955,272 -$372,039 $1,274,562 Value of change ($) $8,955,272 $3,009,541 $2,187,117 $1,865,321 $1,430,967 Pharmacy Volume Volume Change Top Molecule Growth QRT vs same QRT LY ROSUVASTATIN SACUBITRIL + VALSARTAN ATORVASTATIN Value ($) $23,787,943 $17,575,926 $9,760,119 $9,521,115 $8,744,870 Value Change (%) 26% 64% 31% Volume (units) 3,692,854 94,231 3,367,965 3,310 1,988,495 Volume change (%) 34% 64% 34% 3,279,138 17% SOFOSBUVIR + VELPATASVIR GLECAPREVIR + PIBRENTASVIR BICTEGRAVIR + EMTRICITABINE + TENOFOVIR ALAFENAMIDE EMTRICITABINE + TENOFOVIR DISOPROXIL TENOFOVIR DISOPROXIL Value ($) $31,273,077 $21,003,456 $10,120,686 $9,298,771 $6,533,845 Value Change (%) -29% -9% 768% -4% 24% Value Change (%) 768% 516% NA 52% 61% Value ($) $62,719,373 $21,133,763 $18,892,549 $11,162,650 $8,377,297 Volume (units) 2,488 1,121 10,607 60,222 18,208 Volume change (%) -18% -9% 767% 43% 37% Volume change (%) 767% 510% NA 44% 59% Volume (units) 57,592 2,374 3,785,631 2,146,193 10,681 THE PHARMACY STATE OF THE INDUSTRY REPORT 41 RETAIL PHARMACY • JUL 2020